Drug Information Association (DIA) – EU regulators report steady progress in real-world data (RWD) acceptance at DIA Europe 2025 conference
The DIA European annual meeting took place in Basel, Switzerland from 18-20 March 2025. During a panel discussion, representatives from the EMA, Germany’s Federal Institute for Drugs and Medical Devices (BfArM) and the pharmaceutical industry (specifically Sanofi) discussed the progress made in using RWD for regulatory procedures and the importance of RWD in informing decision making for new drug approvals as well as improving drug safety data collection. Please find further information here.
News reported on the 2nd of April 2025 in Catapult’s regulatory round-up, read the entire report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (20 mai 2025). Drug Information Association (DIA) – EU regulators report steady progress in real-world data (RWD) acceptance at DIA Europe 2025 conference. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/13yk0





